FR5940M - - Google Patents

Info

Publication number
FR5940M
FR5940M FR80370A FR80370A FR5940M FR 5940 M FR5940 M FR 5940M FR 80370 A FR80370 A FR 80370A FR 80370 A FR80370 A FR 80370A FR 5940 M FR5940 M FR 5940M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR80370A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR80370A priority Critical patent/FR5940M/fr
Application granted granted Critical
Publication of FR5940M publication Critical patent/FR5940M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
FR80370A 1966-10-18 1966-10-18 Expired FR5940M (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR80370A FR5940M (ja) 1966-10-18 1966-10-18

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR80370A FR5940M (ja) 1966-10-18 1966-10-18

Publications (1)

Publication Number Publication Date
FR5940M true FR5940M (ja) 1968-04-08

Family

ID=8619319

Family Applications (1)

Application Number Title Priority Date Filing Date
FR80370A Expired FR5940M (ja) 1966-10-18 1966-10-18

Country Status (1)

Country Link
FR (1) FR5940M (ja)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1041880A1 (en) * 1997-09-17 2000-10-11 Strategic Science & Technologies, Inc. A delivery of arginine to cause beneficial effects
EP1310174A1 (en) * 2001-11-07 2003-05-14 Hikari Seika Co., Ltd. Taste-improving agent
WO2006012615A2 (en) * 2004-07-22 2006-02-02 Shanbrom Technologies, Llc Lysine citrate for plasma protein and donor protection
US8603519B2 (en) 1997-09-17 2013-12-10 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
US8604081B2 (en) 2009-06-24 2013-12-10 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
US9289495B2 (en) 2010-12-29 2016-03-22 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
US9463158B2 (en) 2009-06-24 2016-10-11 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1041880A1 (en) * 1997-09-17 2000-10-11 Strategic Science & Technologies, Inc. A delivery of arginine to cause beneficial effects
EP1041880A4 (en) * 1997-09-17 2006-04-12 Strategic Science & Technologi ADMINISTRATION OF ARGININE TO OBTAIN A WELLBEING EFFECT
US8603519B2 (en) 1997-09-17 2013-12-10 Strategic Science & Technologies, Llc Topical delivery of L-arginine to cause beneficial effects
EP1310174A1 (en) * 2001-11-07 2003-05-14 Hikari Seika Co., Ltd. Taste-improving agent
US9226909B2 (en) 2004-04-19 2016-01-05 Strategic Science & Technologies, Llc Beneficial effects of increasing local blood flow
WO2006012615A2 (en) * 2004-07-22 2006-02-02 Shanbrom Technologies, Llc Lysine citrate for plasma protein and donor protection
WO2006012615A3 (en) * 2004-07-22 2006-06-01 Shanbrom Tech Llc Lysine citrate for plasma protein and donor protection
US9161915B2 (en) 2009-06-24 2015-10-20 Strategic Science & Technologies, Llc Delivery of ibuprofen and other compounds
US9155701B2 (en) 2009-06-24 2015-10-13 Strategic Science & Technologies, Llc Delivery of ibuprofen and other compounds
US8604081B2 (en) 2009-06-24 2013-12-10 Strategic Science & Technologies, Llc Topical composition containing ibuprofen
US9457092B2 (en) 2009-06-24 2016-10-04 Strategic Science & Technologies, Llc Delivery of ibuprofen and other compounds
US9463158B2 (en) 2009-06-24 2016-10-11 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US9492458B2 (en) 2009-06-24 2016-11-15 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US10172865B2 (en) 2009-06-24 2019-01-08 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications
US9289495B2 (en) 2010-12-29 2016-03-22 Strategic Science & Technologies, Llc Systems and methods for treatment of allergies and other indications
US9498482B2 (en) 2010-12-29 2016-11-22 Strategic Science & Technologies, Llc Treatment of erectile dysfunction and other indications

Similar Documents

Publication Publication Date Title
AT281852B (ja)
AU5917865A (ja)
AU428063B2 (ja)
AU424443B2 (ja)
AU433222B2 (ja)
AU415165B1 (ja)
AU414526B2 (ja)
AU417216B2 (ja)
JPS4618839Y1 (ja)
AU1144366A (ja)
AU218666A (ja)
AU5895065A (ja)
AU6703465A (ja)
AU1111066A (ja)
AU612166A (ja)
AU855865A (ja)
BE447356A (ja)
AU6852465A (ja)
AU411645B2 (ja)
BE694250A (ja)
BE694209A (ja)
BE529218A (ja)
BE475118A (ja)
BE674987A (ja)
BE675084A (ja)